Company Filing History:
6 out of 151 
Years Active: 2017-2018
Title: **Ernst Böhm: Innovator in Factor X Activation**
Introduction
Ernst Böhm, located in Vienna, Austria, is a distinguished inventor with a focused expertise in biochemistry and molecular biology. With three patents to his name, he has significantly contributed to advancements in Factor X activation, a crucial aspect of the coagulation process.
Latest Patents
Among his notable inventions is a set of patents centered on Factor X activation. These include innovative methods and systems for activating Factor X. One of his recent patents details the production of fully processed and functional Factor X in a furin-secreting mammalian expression system. This patent outlines methods for achieving the controlled production of mature Factor X, utilizing an expression system that generates a specified amount of furin within the culture supernatant, with concentrations ranging from 50 U/mL to 300 U/mL. Additionally, this invention covers transformed cells, expression systems, and expression vectors required for the successful expression of both furin and Factor X.
Career Highlights
Ernst Böhm is currently affiliated with Baxalta GmbH, a company renowned for its innovations in biopharmaceuticals. His research and development efforts have played a pivotal role in advancing therapeutic solutions that address complex health challenges. Böhm's disciplined approach towards his work has positioned him as a key player in the field of coagulation research.
Collaborations
Throughout his career, Böhm has collaborated with various experts, including notable colleagues such as Michael Dockal and Franziska Horling. These collaborative efforts have not only enhanced his work but also fostered a dynamic research environment that emphasizes innovation and discovery in the realm of biomedicine.
Conclusion
Ernst Böhm exemplifies the spirit of innovation in the scientific community. His contributions to the field of Factor X activation showcase not only his technical skills but also his commitment to developing solutions that can potentially transform patient care. With a focus on collaboration and continuous improvement, Böhm’s work remains crucial in advancing our understanding and treatment of coagulation disorders.